Skip to main content

CND’s Synuclein-One Study Results Published in the Journal of American Medical Association. See the abstract

Senior woman header
Senior woman header
Photo header of senior man
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE®

CND’s Syn-One Test® offers physicians and patients an accurate, convenient, evidence-based tool to help diagnose a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND’s Syn-One Test® offers physicians and patients an accurate, convenient, evidence-based tool to help diagnose a synucleinopathy. And our mission has just begun.

Learn More

Introducing the Syn-One Test® from CND Life Sciences

The first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.

seal icon

CLIA-Certified and CAP-Accredited Pathology Lab

test tube icon

Dedication to Science, Research, Quality, and Reliability

DNA icon

Patient-Focused Mission

microscope icon

High Accuracy: >95% Sensitivity and Specificity

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

CND Insights

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
September 26, 2024

For Patients: Answers to Your Questions About the Syn-One Test®

A core value of CND Life Sciences is putting patients first. We understand that when…
Insights
August 12, 2024

The Skin You’re In: A Window to the Nervous System

As an interface to the outside world and the largest organ in the body, the…
Insights
July 15, 2024

CND Life Sciences’ Director of Medical Affairs Discusses Syn-One Test® With Synapticure Neurologists

Dr. Padma Mahant, MD, Director of Medical Affairs at CND Life Sciences, recently participated in…
VIEW ALL INSIGHTS

News

Check out press releases, news alerts and coverage of CND happenings.

CND In the News
October 14, 2024

CND Life Sciences Featured in Washington Post Article About Challenges in Diagnosing Parkinson’s

CND Life Sciences and its Syn-One Test® were highlighted in a Washington Post article this…
On Our Radar
October 7, 2024

Study Helps Identify Which Patients With REM Sleep Behavior Disorder May Develop Dementia With Lewy Bodies

Isolated/idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is a strong predictor of Parkinson’s…
On Our Radar
September 13, 2024

Gut Microbiome May Play a Role in Parkinson’s Disease

A healthy diet may positively affect the gut microbiome of patients with Parkinson’s disease, according…
VIEW ALL NEWS
CND CASE STUDIES

For Clinicians: Request a Skin Biopsy Test Kit

Our suite of neurodiagnostic tests provides clinicians with objective pathological insights on diseases that are often difficult to diagnose. Using our Skin Biopsy Test Kit, collect three small skin biopsies from your patient, send them to our CLIA-certified and CAP-accredited lab, and CND will provide important pathological insights to support a diagnosis.

Order a Kit